[EN] TISSUE SELECTIVE STEAROYL-COA DESATURASE 1 INHIBITORS AND CELL BASED SCREENING ASSAY FOR THEIR IDENTIFICATION<br/>[FR] INHIBITEURS DE LA STÉAROYL-COA DÉSATURASE 1 SÉLECTIVE DE TISSU ET ANALYSE DE CRIBLAGE À BASE DE CELLULE POUR LEUR IDENTIFICATION
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2010035052A1
公开(公告)日:2010-04-01
The present invention provides a method of treating a disorder treatable by administering a therapeutically effective amount of a tissue selective Stearoyl-CoA Desaturase 1 (SCD-1) modulator to a subject. In one embodiment, the present invention provides a method of treating a disorder treatable by administering a pharmaceutically effective amount of a tissue selective SCD-1 inhibitor to a subject. The invention also provides whole cell based screening assays to identify agents that selectively modulate the activity of SCD-1. This invention further provides whole cell based screening assays to identify agents that differentially inhibit SCD in different body tissues.
[EN] THIAZOLE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS<br/>[FR] DÉRIVÉS DE THIAZOLE EN TANT QU'INHIBITEURS DE STÉAROYL-COA DÉSATURASE